Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke

NCT05547412 is registered in ClinicalTrials.gov with NeuraSignal Inc dba NovaSignal as lead sponsor.

NCT NCT05547412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05547412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke
Lead sponsor
NeuraSignal Inc dba NovaSignal
Phase
Observational
Overall status
Terminated
Start date
September 21, 2022
Completion date
January 31, 2023
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, stroke